Fucoxanthin Caffeine Ephedrine Composition for Thermogenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current weight management approaches for obesity and overweight are multifactorial and lack effective therapies that are compatible with dietary modification, with a gap in using combinations of stimulant and non-stimulant thermogenic agents to enhance thermogenesis.
Innovation Solution
A composition comprising fucoxanthin, caffeine, and ephedra or ephedrine alkaloids, along with other thermogenic agents, is used to synergistically enhance thermogenesis, addressing the challenge by combining stimulant and non-stimulant compounds to promote weight loss and metabolic rate increase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If stimulant-based thermogenic agents are used alone, then thermogenic effect is achieved, but side effects and tolerance issues worsen
Solution Approach 1:
The patent combines stimulant-based thermogenic agents (e.g., caffeine, ephedrine) with non-stimulant thermogenic agents (e.g., green tea extract, fucoxanthin) in a single composition. This merging of different agent types with complementary mechanisms of action enhances the overall thermogenic effect while distributing and potentially reducing the side effects associated with high doses of stimulant agents alone.
Solution Approach 2:
The invention creates a composite thermogenic composition that integrates multiple ingredients with different properties - stimulants that activate the central nervous system and non-stimulants that act through other pathways such as beta-oxidation enhancement and uncoupling protein expression. This composite approach allows synergistic interaction between components, achieving greater thermogenic efficacy with reduced individual component dosages and associated side effects.
2Object-affected harmful factors
If non-stimulant thermogenic agents are used alone, then side effects are reduced, but thermogenic efficacy is insufficient
Solution Approach 1:
The patent merges non-stimulant thermogenic agents (e.g., green tea catechins, fucoxanthin) with stimulant agents (e.g., caffeine, ephedrine) to create a synergistic composition. The non-stimulants contribute mechanisms such as inhibition of fat absorption, enhancement of beta-oxidation, and upregulation of uncoupling proteins, while stimulants provide central nervous system activation and increased metabolic rate, together achieving superior thermogenic efficacy compared to non-stimulants alone.
Solution Approach 2:
The invention formulates a composite product that integrates multiple thermogenic mechanisms in one composition. The non-stimulant components address lipid metabolism through peripheral mechanisms while stimulant components provide central activation, creating a multi-faceted approach to thermogenesis that overcomes the limited efficacy of non-stimulants used in isolation.
3Use of energy by moving object
If combinations of stimulant and non-stimulant thermogenic agents are used, then thermogenic efficacy is enhanced, but composition complexity increases
Solution Approach 1:
The patent creates a universal thermogenic composition that integrates multiple functional ingredients into a single multi-functional product. Each ingredient contributes specific thermogenic mechanisms - stimulants for CNS activation, green tea extract for catechin-mediated fat oxidation, fucoxanthin for uncoupling protein expression, and other components addressing different aspects of energy metabolism. This multi-functional formulation delivers comprehensive thermogenic coverage in one product, reducing the need for multiple separate supplements.
Solution Approach 2:
The invention merges multiple thermogenic agents with different mechanisms of action into a single integrated composition. By combining stimulants, green tea extract, fucoxanthin, and other thermogenic ingredients in carefully formulated ratios, the patent creates a unified product that leverages synergistic interactions between components, achieving enhanced thermogenic efficacy while presenting a single convenient formulation rather than requiring users to combine multiple separate products.
Data Source
AI summary
The present invention refers to novel compositions and to methods of using the compositions to treat and/or prevent obesity, obesity-related diseases or disorders (e.g., hyperglycemia, hyperinsulinemia, elevated hemoglobin A1c (HbA1c), diabetes, or cardiovascular disease), and overweight. This invention also generally relates to compositions and to methods of using the compositions to increase basal metabolic rate.